Twist Bioscience vs Ankr

Side-by-side comparison of AI visibility scores, market position, and capabilities

Ankr leads in AI visibility (33 vs 16)
Twist Bioscience logo

Twist Bioscience

GrowthLife Sciences & BioTech

Synthetic Biology & DNA Synthesis

Synthetic DNA manufacturing platform on silicon chips; $376M FY2025 revenue (+20% YoY). Supplies synthetic genes to 3,000+ customers across biotech, pharma, and AgBio.

AI VisibilityBeta
Overall Score
D16
Category Rank
#1 of 1
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
20
Perplexity
10
Gemini
23

About

Twist Bioscience was founded in 2013 in San Francisco by Emily Leproust, Bill Banyai, and Bill Peck, pioneering a silicon-based DNA synthesis platform that writes synthetic DNA at a fraction of the cost and error rate of conventional methods. By printing DNA on silicon wafers using a semiconductor-like process, Twist dramatically reduced the cost of synthetic genes from hundreds to single-digit dollars per gene, democratizing access to DNA writing for the life sciences.\n\nTwist serves over 3,000 customers across biopharmaceuticals, academic research, agriculture, and industrial biotechnology, offering synthetic genes, variant libraries, DNA data storage oligos, and antibody libraries for drug discovery. The company reported $376.6 million in FY2025 revenue, up 20% from $313 million in FY2024, driven by strong growth in its biopharma and drug discovery segments. Twist also operates a growing antibody drug discovery business, providing synthetic antibody libraries that power next-generation therapeutic discovery programs.\n\nTwist has a supply agreement with Ginkgo Bioworks for synthetic DNA to fuel Ginkgo's cell engineering platform, revised in 2025. The company is executing toward profitability, with improving gross margins as manufacturing scale increases. Its silicon-based DNA synthesis platform positions it as critical infrastructure for the emerging bioeconomy, synthetic biology, and DNA data storage industries.

Full profile
Ankr logo

Ankr

EmergingWeb3

Multi-Chain RPC Infrastructure

Decentralized Web3 infrastructure with RPC node access across 30+ blockchains; globally distributed nodes reduce latency; premium dedicated nodes for apps needing guaranteed throughput.

AI VisibilityBeta
Overall Score
D33
Category Rank
#1 of 1
AI Consensus
56%
Trend
up
Per Platform
ChatGPT
40
Perplexity
40
Gemini
29

About

Ankr is a Web3 infrastructure platform offering remote procedure call node access to more than 30 blockchain networks through a globally distributed network of nodes run by independent operators. Unlike centralized providers that operate their own data centers exclusively, Ankr's decentralized architecture routes requests across geographically distributed nodes, improving latency for users in regions underserved by US- or EU-centric infrastructure. Its public free-tier RPC endpoints — available for Ethereum, BNB Chain, Polygon, Avalanche, Fantom, and dozens of others — have made Ankr one of the most widely used infrastructure providers in the multi-chain developer ecosystem.

Full profile

AI Visibility Head-to-Head

16
Overall Score
33
#1
Category Rank
#1
68
AI Consensus
56
up
Trend
up
20
ChatGPT
40
10
Perplexity
40
23
Gemini
29
17
Claude
25
13
Grok
40

Key Details

Category
Synthetic Biology & DNA Synthesis
Multi-Chain RPC Infrastructure
Tier
Growth
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Twist Bioscience
Synthetic Biology & DNA Synthesis
Only Ankr
Multi-Chain RPC Infrastructure

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.